RICHMOND, Va. (WRIC) – Virginia Commonwealth University Health volunteers will enroll in a new clinical trial that tests three new drugs, called ‘immune modulator’ drugs, on those hospitalized with COVID-19.
Health officials explain the drugs focus on the ‘cytokine storm’ which occurs when the body begins to attack itself rather than the virus.
Health experts hope the drugs help restore the immune system.
“The cytokine storm can lead to respiratory distress, organ failure and other life-threatening complications, so a drug that counteracts these symptoms could reduce fatalities, shorten hospital stays and lessen the need for ventilators,” trial lead Arun Sanyal, M.D., a professor in the Department of Internal Medicine in the VCU School of Medicine said.
The three new study drugs being studied, called infliximab, abatacept and cenicriviroc, will be added to remdesivir, a treatment for COVID-19 that’s been approved by the FDA. All participants will receive remdesivir, and the trial will test whether adding one of the new study drugs is effective for treatment of the virus.
The National Institutes of Health launched the trial back in October. To learn more about VCU clinical trials, click here.
- AUBURN, Ala. (WRBL) – Treating vaccine hesitancy with care and compassion may be what the doctor ordered. An Auburn University Emeritus Professor, who's dedicated his professional life to improving treatment goals for patients, believes COVID-19 vaccine hesitancy is best addressed through compassionate conversations between healthcare providers and those who worry about getting the shot. Dr. […]
- The Richmond City Health District has unveiled a specially equipped van to turn their vaccination efforts mobile. The goal is to use the van to help reach areas of the city that need help receiving the vaccine.
- Until Wednesday, these reports were not seen by the public, except in a few rare leaks.
- Virginia Is Failing in Tobacco Prevention As Smokers See An Increased Risk For Severe Illness From COVID-19The Centers for Disease Control has concluded smokers have an increased risk for a severe illness from COVID-19. Yet a new report shows Virginia is still failing when it comes to tobacco prevention and control.
- Chesterfield County officials are dealing with a case of balancing expectations with obtainable goals when it comes to vaccinating eligible populations against COVID-19.
- The Virginia House and Senate have unanimously advanced separate bills to facilitate administration of the COVID-19 vaccine.
- The Oklahoma attorney general's office is attempting to return $2 million worth of a malaria drug once touted by former President Donald Trump as an effective treatment for COVID-19, a spokesman said Wednesday.
- Following recent state guidance to prioritize getting high-risk community members their first dose of the COVID-19 vaccine, the VCU Health system has begun rescheduling appointments for second vaccine doses.
- Amid the COVID-19 pandemic set to kill well over two million people around the globe, an international countdown of what leading science and security experts say represents a threat to human existence remains stuck at about a two minute warning.
- The spread of the coronavirus across the Southwest U.S. may be attributed to visits to Las Vegas, according to a study from smart thermometer company Kinsa Health.